267 related articles for article (PubMed ID: 9739048)
1. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.
Zhai Y; Guo R; Hsu TL; Yu GL; Ni J; Kwon BS; Jiang GW; Lu J; Tan J; Ugustus M; Carter K; Rojas L; Zhu F; Lincoln C; Endress G; Xing L; Wang S; Oh KO; Gentz R; Ruben S; Lippman ME; Hsieh SL; Yang D
J Clin Invest; 1998 Sep; 102(6):1142-51. PubMed ID: 9739048
[TBL] [Abstract][Full Text] [Related]
2. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY
Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518
[TBL] [Abstract][Full Text] [Related]
3. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor.
Morel Y; Schiano de Colella JM; Harrop J; Deen KC; Holmes SD; Wattam TA; Khandekar SS; Truneh A; Sweet RW; Gastaut JA; Olive D; Costello RT
J Immunol; 2000 Oct; 165(8):4397-404. PubMed ID: 11035077
[TBL] [Abstract][Full Text] [Related]
6. Recombinant, soluble LIGHT (HVEM ligand) induces increased IL-8 secretion and growth arrest in A375 melanoma cells.
Hehlgans T; Männel DN
J Interferon Cytokine Res; 2001 May; 21(5):333-8. PubMed ID: 11429164
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes.
Gill RM; Ni J; Hunt JS
Am J Pathol; 2002 Dec; 161(6):2011-7. PubMed ID: 12466117
[TBL] [Abstract][Full Text] [Related]
8. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.
Harrop JA; McDonnell PC; Brigham-Burke M; Lyn SD; Minton J; Tan KB; Dede K; Spampanato J; Silverman C; Hensley P; DiPrinzio R; Emery JG; Deen K; Eichman C; Chabot-Fletcher M; Truneh A; Young PR
J Biol Chem; 1998 Oct; 273(42):27548-56. PubMed ID: 9765287
[TBL] [Abstract][Full Text] [Related]
9. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.
Mauri DN; Ebner R; Montgomery RI; Kochel KD; Cheung TC; Yu GL; Ruben S; Murphy M; Eisenberg RJ; Cohen GH; Spear PG; Ware CF
Immunity; 1998 Jan; 8(1):21-30. PubMed ID: 9462508
[TBL] [Abstract][Full Text] [Related]
10. Light stimulates IFNgamma-mediated intercellular adhesion molecule-1 upregulation of cancer cells.
Zhang M; Guo R; Zhai Y; Fu XY; Yang D
Hum Immunol; 2003 Apr; 64(4):416-26. PubMed ID: 12651068
[TBL] [Abstract][Full Text] [Related]
11. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
[TBL] [Abstract][Full Text] [Related]
12. Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells.
Stopfer P; Männel DN; Hehlgans T
J Immunol; 2004 Jun; 172(12):7459-65. PubMed ID: 15187124
[TBL] [Abstract][Full Text] [Related]
13. Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.
Bechill J; Muller WJ
Mol Immunol; 2014 Nov; 62(1):96-103. PubMed ID: 24980868
[TBL] [Abstract][Full Text] [Related]
14. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
[TBL] [Abstract][Full Text] [Related]
16. A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production.
Pasero C; Barbarat B; Just-Landi S; Bernard A; Aurran-Schleinitz T; Rey J; Eldering E; Truneh A; Costello RT; Olive D
Eur J Immunol; 2009 Sep; 39(9):2502-14. PubMed ID: 19701890
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3.
You RI; Chen MC; Wang HW; Chou YC; Lin CH; Hsieh SL
Cancer Res; 2006 Mar; 66(6):3051-61. PubMed ID: 16540654
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.
Shaikh RB; Santee S; Granger SW; Butrovich K; Cheung T; Kronenberg M; Cheroutre H; Ware CF
J Immunol; 2001 Dec; 167(11):6330-7. PubMed ID: 11714797
[TBL] [Abstract][Full Text] [Related]
19. Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis.
Anand S; Wang P; Yoshimura K; Choi IH; Hilliard A; Chen YH; Wang CR; Schulick R; Flies AS; Flies DB; Zhu G; Xu Y; Pardoll DM; Chen L; Tamada K
J Clin Invest; 2006 Apr; 116(4):1045-51. PubMed ID: 16557300
[TBL] [Abstract][Full Text] [Related]
20. Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling.
An MM; Fan KX; Cao YB; Shen H; Zhang JD; Lu L; Gao PH; Jiang YY
Biol Pharm Bull; 2006 Oct; 29(10):2025-30. PubMed ID: 17015945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
